Rachael A. Pearson

Social SciencesMedicinePharmacology, Toxicology and Pharmaceutics

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Pharmacogenomics in kidney transplant recipients and potential for integration into practice”.

Pharmacogenomics in kidney transplant recipients and potential for integration into practice

Journal of Clinical Pharmacy and Therapeutics(2020)10.1111/jcpt.13223

N/A

0.526DataRank · unranked

9 citations

Rachael A. Pearson, Moataz E. Mohamed, David P. Schladt, Danielle Berglund, Zachary Rivers +13 more

Higher Fludarabine and Cyclophosphamide Exposures Lead to Worse Outcomes in Reduced-Intensity Conditioning Hematopoietic Cell Transplantation for Adult Hematologic Malignancy

Transplantation and Cellular Therapy(2021)10.1016/j.jtct.2021.05.013

N/A

0DataRank · unranked

5 citations

Aileen Scheibner, Qing Cao, Rachael A. Pearson, Kinjal Sanghavi, Daniel J. Weisdorf +7 more

Effects of cyclophosphamide related genetic variants on clinical outcomes of adult hematopoietic cell transplant patients

Cancer Chemotherapy and Pharmacology(2022)10.1007/s00280-021-04389-w

N/A

0DataRank · unranked

6 citations

Rachael A. Pearson, Qing Cao, Aileen Scheibner, Kinjal Sanghavi, Daniel J. Weisdorf +7 more